FK506 Binding Protein 6, 36kDa (FKBP6) (Middle Region) Peptide
Quick Overview for FK506 Binding Protein 6, 36kDa (FKBP6) (Middle Region) Peptide (ABIN8100744)
Target
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- FKBP6 Peptide - middle region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-MTA2 antibody ( ARP43599_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- FKBP6 (FK506 Binding Protein 6, 36kDa (FKBP6))
-
Background
-
Background Information: FKBP6 is a member of the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. FKBP6 is a cis-trans prolyl isomerase that binds to the immunosuppressants FK506 and rapamycin.This gene encodes a member of the interferon regulatory transcription factor (IRF) family. Family members share a highly-conserved N-terminal helix-turn-helix DNA-binding domain and a less conserved C-terminal protein-binding domain. Mutations in this gene can cause van der Woude syndrome and popliteal pterygium syndrome. This protein is involved in palate formation.
Alternative Symbols: FKBP36, MGC87179, PPIase
-
Molecular Weight
- 36kDa
-
Gene ID
- 8468
-
NCBI Accession
- NP_003593
-
UniProt
- O75344
Target
-
